Substance
TASIMELTEON
Global reference: every product and company linked to this substance.
- cas: 609799-22-6
- ncit: C152515
- pubchem_cid: 10220503
- rxnorm: 1490468
- unii: SHS4PU80D9
BMS-214,778 · BMS-214778 · HETLIOZ · HETLIOZ LQ · tasimelteon [INN] · TASIMELTEON [USAN] · Tasimelteon [WHO-DD] · VEC-162
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| VANDA PHARMACEUTICALS INC. COMMON STOCK | HETLIOZ | Q2 2026 | $5.6M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- HETLIOZ · VANDA PHARMACEUTICALS INC. COMMON STOCK
- HETLIOZ LQ · VANDA PHARMACEUTICALS INC. COMMON STOCK
- TASIMELTEON · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES